Remission status and cortical thickness in childhood-onset schizophrenia.

Journal of the American Academy of Child and Adolescent Psychiatry
Deanna GreensteinNitin Gogtay

Abstract

Few studies have examined prediction of schizophrenia outcome in relation to brain magnetic resonance imaging measures. In this study, remission status at the time of discharge was examined in relation to admission cortical thickness for childhood-onset schizophrenia probands. We hypothesized that total, frontal, temporal, and parietal gray matter thickness would be greater in patients who subsequently remit. The relation between admission cortical brain thickness on magnetic resonance imaging and remission status at the time of discharge an average of 3 months later was examined for 56 individuals (32 males) ages 6 to 19 diagnosed with childhood-onset schizophrenia. Cortical thickness was measured across the cerebral hemispheres at admission. Discharge remission criteria were adapted from the 2005 Remission in Schizophrenia Working Group criteria. Patients remitted at discharge (n = 16 [29%]) had thicker regional cortex in left orbitofrontal, left superior, and middle temporal gyri and bilateral postcentral and angular gyri (p < or = .008). Our results provide neuroanatomic correlates of clinical remission in schizophrenia and evidence that response to treatment may be mediated by these cortical brain regions.

References

Nov 1, 1983·Archives of General Psychiatry·D ShafferS Aluwahlia
Jun 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·K McKennaJ L Rapoport
Dec 1, 1996·Archives of General Psychiatry·S KumraJ L Rapoport
Jun 9, 1998·IEEE Transactions on Medical Imaging·J G SledA C Evans
May 2, 2000·The British Journal of Psychiatry : the Journal of Mental Science·S K BerumentA Bailey
Aug 2, 2000·Archives of General Psychiatry·R E GurR C Gur
Mar 20, 2001·Archives of General Psychiatry·F X CastellanosJ L Rapoport
Mar 21, 2001·Biological Psychiatry·J LiebermanR Bilder
May 10, 2001·Schizophrenia Research·M E ShentonR W McCarley
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·P M ThompsonJ L Rapoport
Feb 15, 2003·IEEE Transactions on Medical Imaging·Alex P ZijdenbosAlan C Evans
Sep 27, 2003·Schizophrenia Research·Neeltje E M van HarenRené S Kahn
Nov 26, 2003·The American Journal of Psychiatry·Alexandra L SpornJudith L Rapoport
Sep 29, 2004·Medical Image Analysis·Steven RobbinsSue Whitesides
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Nov 1, 2005·Psychiatry Research·Konasale M R PrasadMatcheri S Keshavan
Nov 1, 2006·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Deanna GreensteinNitin Gogtay
Nov 1, 2006·The American Journal of Psychiatry·Jim van OsPhilippe Delespaul
Nov 11, 2006·Schizophrenia Research·Robin EmsleyUNKNOWN Early Psychosis Global Working Group
Nov 30, 2006·European Psychiatry : the Journal of the Association of European Psychiatrists·E LauronenM Isohanni
Jan 24, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Acioly L T LacerdaMatcheri S Keshavan
Mar 10, 2007·Brain : a Journal of Neurology·Motoaki NakamuraMartha E Shenton
Jul 4, 2007·Archives of General Psychiatry·Nitin GogtayJudith Rapoport
Apr 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Philip ShawSteve P Wise

❮ Previous
Next ❯

Citations

May 24, 2013·Brain : a Journal of Neurology·Marcel E MoranNitin Gogtay
Oct 9, 2012·Child and Adolescent Psychiatric Clinics of North America·Manpreet K Singh, Kiki D Chang
Aug 30, 2012·The Psychiatric Clinics of North America·John G Kerns, John Lauriello
Nov 17, 2009·Schizophrenia Research·Anand MattaiNitin Gogtay
Oct 1, 2008·Journal of the American Academy of Child and Adolescent Psychiatry·Sanjiv Kumra
Aug 30, 2011·Journal of the American Academy of Child and Adolescent Psychiatry·James F Leckman
Apr 3, 2013·Expert Review of Neurotherapeutics·Christopher N DavidNitin Gogtay
Jan 1, 2015·NPJ Schizophrenia·Covadonga M Díaz-CanejaCelso Arango

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here